Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2011-01-25
2011-11-08
Monshipouri, Maryam (Department: 1656)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
Reexamination Certificate
active
08053207
ABSTRACT:
Methods for cancer diagnosis and treatment; in particular, methods for diagnosis and treatment of triple negative breast cancer by measuring the activity of PMPMEase.
REFERENCES:
patent: 5202456 (1993-04-01), Rando
patent: 5574025 (1996-11-01), Anthony
patent: 5705528 (1998-01-01), Kloog
patent: 6372793 (2002-04-01), Lamango et al.
patent: 7897604 (2011-03-01), Lamango
Perez-Sala et al., “Prenylated protein methyltransferases do not distinguish between farnesylated and geranylgeranylated substrates”, Biochem J. 284:835-840 (1992).
Regazzi et al., “Prenylcysteine analogs mimicking the C-terminus of GTP-binding proteins stimulate exocytosis from permeabilized HIT-T15 cells: comparison with the effect of Rab3AL peptide”, BBA 1268:269-278 (1995).
Roskoski, Jr., “Protein prenylation: a pivotal posttranslational process”, BBRC 303:1-7 (2003).
Sinensky, “Recent advances in the study of prenylated proteins”, BBA 1484:93-106 (2000).
Muhlig-Versen et al., “Loss of Swiss Cheese/Neuropathy Target Esterase Activity Causes Disruption of Phosphatidylcholine Homeostasis and Neuronal and Glial Death in AdultDrosophila”, J Neurosci 25(11):2865-2873 (2005).
Morris et al., “Physiological Regulation of G Protein-Linked Signaling”, Physio Rev 79(4):1373-1429 (1999).
Winter-Vann et al., “A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells”, PNAS 102(12):4336-4341, 2005.
Lutz et al. “Feedback Inhibition of Polyisoprenyl Pyrophosphate Synthesis from Mevalonate in Vitro”, J Bio Chem 267 (12):7983-7986 (1992).
Sinensky et al., “Functional aspects of polyisoprenoid protein substituents: roles in protein-protein interaction and trafficking”, BBA 1529:203-209 (2000).
Sharar et al., “Extrapyramidal Parkinsonism Complicating Acute Organophosphate Insecticide Poisoning”, Pediatric Neur 33(4):378-382 (2005).
Khosravi-Far et al., “Ras (CXXX) and Rab (CC/CXC) Prenylation Signal Sequences Are Unique and Functionally Distinct”, J Bio Chem 267(34):24363-24368 (1992).
Ma et al., “Mechanistic Studies on Human Platelet Isoprenylated Protein Methyltransferase: Farnesylcysteine Analogs Block Platelet Aggregation without Inhibiting the Methyltransferase”, Biochemistry 33:5414-5420 (1994).
Muller-Vahl et al., “Transient Severe Parkinsonism After Acute Organophosphate Poisoning”, J Neurol Neurosurg Psychiatry 66:253-254 (1999).
Myung et al., “Role of Isoprenoid Lipids on the Heterotrimeric G Protein Gamma Subunit in Determining Effector Activiation”, J Biol Chem 274(23):16595-16603 (1999).
Pereira-Leal, et al., “Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease”, FEBS 498:197-200 (2001).
Anderegg, at al., “Structure ofSaccharomyces cerevisiaeMating Hormone A-Factor. Identification of S-Farnesyl Cysteine as a Structural Component”, J Bio Chem, 263:18236-18240 (1988).
Anderson, et al., “Purification, functional Reconstitution and Characterization of theSaccharomyces cerevisiaeIsoprenylcysteine Carboxylmethyltransferase”, J Bio Chem 280:7336-7345 (2005).
Ascherio, et al., “Pesticide Exposure and Risk for Parkinson's Disease”, Ann Neurol 60:197-203 (2006).
Becker, et al., “Synthesis and Structure-Activity Relationships of Beta and Alpha Piperidine Sulfone Hydroxamic Acid Matrix Metalloproteinase Inhibitors With Oral Antitumor Efficacy”, J Med Chem 48:6713-6730 (2005).
Bergo, et al., “Isoprenylcysteine Carboxyl Methyltransferase Deficiency in Mice”, J Bio Chem 276:5841-5845 (2001).
Bifulco, “Rose of the Isoprenoid Pathway in ras Transforming Activity, Cytoskeleton Organization, Cell Proliferation and Apoptosis”, Life Sciences 771740-1749 (2005).
Calero, et al., “Saccharomyces cerevisiaePra1p/Yip3p Interacts with Yip1p and Rab Proteins”, Biochem Biophys Res Commun 290:676-381 (2002).
Chen, et al., “G Protein Beta2 Subunit Interacts Directly with Neuropathy Target Esterase and Regulates its Activity”, Intl J Biochem & Cell Biology 39:124-132 (2007).
Capdevila et al., “Pancreatic Exocrine Secretion is Blocked by Inhibitors of Methylation”, Arch Biochem Biophys 345:47-55 (1997).
Cohen et al., “Inhibitors of Prenylation of Ras and Other G-Proteins and Their Application as Therapeutics”, Biochem Pharma 60:1061-1068 (2000).
Costa, “Current Issues in Organophosphate Toxicology”, Clin Chem Acta 366:1-13 (2006).
Dietrich, et al., “Isoprenylation of the G Protein Gamma Subunit is Both Necessary and Sufficient for Beta Gamma Dimmer-mediated Stimulation of Phospholipase”, C Biochem 35:15174-15182 (1996).
Ding, et al., “Farnesyt-L-Cysteine Analogs Can Inhibit of Initiate Superoxide Release by Human Neutrophils”, J Biol Chem 269:16837-16844 (1994).
Dolence et al., “A mechanism for posttranslational modifications of proteins by yeast protein farnesyltransferase”, Proc Natl Acad Sci 92:5008-5011 (May 1995).
Ehrhardt et al., “Ras and relatives—job sharing and networking keep an old family together”, Exp Hematology 30:1089-1106 (2002).
Glynn, Paul, “Neuropathy target esterase and phospholipid deacylation”, BBA 1736:87-93 (2005).
Gosser et al., “C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases”, Nature 387:814-819 (Jun. 19, 1997).
Kloog et al., “Prenyl-binding domains: potential targets for Ras inhibitors and anti-cancer drugs”, Seminars in Cancer Bio 14:253-261 (2004).
Lamango et al., “Quantification of S-Adenosylmethionine-Induced Tremors: A Possible Tremor Model for Parkinson's Disease” Pharm Biochem and Behavior 65(3):523-529 (2000).
Lebowitz et al, “Farnesyltransferase Inhibitors Alter the Prenylation and Growth-stimulating Function of RhoB”, J Bio Chem 272(25):15591-15594 (Jun. 20, 1997).
Lamango et al., “Liver Prenylated Methylated Protein Methyl Esterase is an Organophosphate-Sensitive Enzyme”, J Biochem Molecular Toxicology 19(5):347-357 (2005).
Marom et al., “Selective Inhibition of Ras-dependent Cell Growth by Farnesylthiosalisylic Acid”, J Bio Chem 270 (38):22263-22270 (Sep. 22, 1995).
Martincic et al., “Isolation and Characterization of a Dual Prenylated Rab and VAMP2 Receptor”, J Bio Chem 272 (43):26991-26998 (Oct. 24, 1997).
McTaggart, S.J., “Isoprenylated proteins”, Cell Mol Life Sci 62:255-267 (2006).
Seabra, et al. “Rab GTPases, Intercellular Traffic and Disease”, Trends in Mol Med 8(1):23-30 (2002).
Seymore, L., “Novel anti-cancer agents in development: exciting prospects and new challenges”, Cancer Treatment Rev 25:301-312 (1999).
Shields et al., “Understanding Ras: ‘it ain't over 'til it's over’”, Trends Cell Bio 10:147-154 (Apr. 2000).
Parish et al., “Isoprenylation/Methylation of Proteins Enhances Membrane Association by a Hydrophobic Mechanism” Biochem 35(26):8473-8477 (1996).
Beard, Esq. Collen A.
Florida Agrlcultural and Mechanical University
Monshipouri Maryam
Parks IP Law LLC
LandOfFree
Cancer diagnosis by measuring polyisoprenylated methylated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer diagnosis by measuring polyisoprenylated methylated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer diagnosis by measuring polyisoprenylated methylated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4289826